Physician profile
John R Hicks
NPI 1528017951
$1,513.96
in general payments reported to CMS, 2019-2025
11 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $81.94 · 2021: $213 · 2022: $321 · 2023: $161 · 2024: $83.82 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $805.81 | 2019-2025 | Acticor 7 Vr-T Dx, Selectra, Renamic Neo |
| Atricure, INC. | $265.70 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $208.88 | 2019-2025 | Watchman Flx, Cds - Mct/Cem Monitoring |
| Novo Nordisk INC | $61.88 | 2025 | Wegovy |
| Cvrx, INC. | $49.47 | 2024-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.86 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $26.42 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $25.49 | 2019 | |
| Abbott Laboratories | $17.57 | 2021 | |
| Medtronic Vascular, INC. | $12.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.